Can a simple mineral boost save more lives in the ICU?
NCT ID NCT07173855
Summary
This study aims to find the best target level for magnesium, a common mineral given in the ICU, to help critically ill patients. It will compare whether aiming for a higher or lower magnesium level leads to better 30-day survival and fewer episodes of a dangerous irregular heartbeat called atrial fibrillation. Over 3,200 patients across several hospitals will be part of this trial, which is integrated into their standard hospital care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lakeridge Health Ajax-Pickering
NOT_YET_RECRUITINGAjax, Ontario, L1S 2J4, Canada
-
Lakeridge Health Oshawa
NOT_YET_RECRUITINGOshawa, Ontario, L1G 8A2, Canada
-
Scarborough Birchmount Hospital
RECRUITINGToronto, Ontario, M1W 3W3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Scarborough Centenary Hospital
RECRUITINGToronto, Ontario, M1E 4B9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Scarborough General Hospital
RECRUITINGToronto, Ontario, M1P2V5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.